DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,115 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $41,765,000 | +14.5% | 161,698 | +12.3% | 0.40% | +21.9% |
| Q2 2022 | $36,488,000 | -8.8% | 143,924 | +5.5% | 0.32% | +8.0% |
| Q1 2022 | $40,006,000 | -15.8% | 136,385 | -5.6% | 0.30% | -12.3% |
| Q4 2021 | $47,517,000 | +7.4% | 144,424 | -0.6% | 0.34% | +0.9% |
| Q3 2021 | $44,225,000 | -17.6% | 145,268 | -27.3% | 0.34% | -15.5% |
| Q2 2021 | $53,660,000 | +37.2% | 199,954 | +15.0% | 0.40% | +29.4% |
| Q1 2021 | $39,119,000 | +6.6% | 173,801 | +5.2% | 0.31% | -1.0% |
| Q4 2020 | $36,685,000 | +5.5% | 165,145 | +2.2% | 0.31% | -10.6% |
| Q3 2020 | $34,785,000 | +25.2% | 161,542 | +2.8% | 0.35% | +19.5% |
| Q2 2020 | $27,779,000 | +28.7% | 157,092 | +0.8% | 0.29% | +12.3% |
| Q1 2020 | $21,579,000 | -9.8% | 155,904 | 0.0% | 0.26% | -9.1% |
| Q4 2019 | $23,928,000 | -0.5% | 155,904 | -6.3% | 0.29% | -4.7% |
| Q3 2019 | $24,039,000 | +3.9% | 166,438 | +2.9% | 0.30% | +7.5% |
| Q2 2019 | $23,127,000 | +7.7% | 161,820 | -0.6% | 0.28% | +16.2% |
| Q1 2019 | $21,483,000 | -5.0% | 162,726 | -25.8% | 0.24% | -10.7% |
| Q4 2018 | $22,615,000 | -3.0% | 219,307 | +2.2% | 0.27% | +14.9% |
| Q3 2018 | $23,311,000 | +15.0% | 214,531 | +4.5% | 0.24% | +13.0% |
| Q2 2018 | $20,262,000 | +0.8% | 205,327 | 0.0% | 0.21% | -4.6% |
| Q1 2018 | $20,104,000 | -16.6% | 205,327 | -20.9% | 0.22% | -6.8% |
| Q4 2017 | $24,105,000 | +6.7% | 259,699 | -1.3% | 0.23% | -5.3% |
| Q3 2017 | $22,581,000 | +1.6% | 263,238 | 0.0% | 0.25% | -2.8% |
| Q2 2017 | $22,216,000 | -0.0% | 263,238 | +1.2% | 0.25% | +5.0% |
| Q1 2017 | $22,220,000 | +10.2% | 260,089 | +0.3% | 0.24% | +4.3% |
| Q4 2016 | $20,162,000 | -0.6% | 259,318 | +0.1% | 0.23% | +2.2% |
| Q3 2016 | $20,291,000 | -0.7% | 259,000 | +28.0% | 0.23% | -0.4% |
| Q2 2016 | $20,437,000 | +8.0% | 202,419 | +1.3% | 0.23% | 0.0% |
| Q1 2016 | $18,924,000 | +4482.1% | 199,749 | +4395.8% | 0.23% | +4460.0% |
| Q4 2015 | $413,000 | – | 4,443 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |